HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

4th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2023 | Boston, Massachusetts, USA

GAB 2022

Frederick J Goldstein

Speaker at Addiction Medicine, Behavioral Health and Psychiatry 2022 - Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Title : Clinical pharmacology of medical marijuana THC update

Abstract:

Marijuana use throughout the world has increased substantially for both recreational and medicinal purposes.  According to the 2022 World Drug Report published by the United Nations Office on Drugs and Crime, cannabis is the most widely used drug on earth. Additional relevant information from this document will be presented.

Other aspects to be discussed regarding clinical pharmacological aspects of marijuana include the endogenous cannabinoid (CB) receptor system, mechanisms of action, adverse effects, addiction liability, physical dependence, withdrawal reactions, contraindications, and drug interactions.

Self-treatment of many conditions includes anxiety, posttraumatic stress disorder (PTSD) and, most significant, chronic pain.  However, high-level clinical research needed to document such applications is lacking. In an ongoing pilot study led by Dr. Goldstein, daily doses of FDA-approved THC over a four-week period have been shown to reduce pain scores and use of other analgesic medications in patients with chronic neuropathic pain; these data will be presented.

Biography:

Dr. Goldstein is Professor of Clinical Pharmacology in the Department of Bio-Medical Sciences at PCOM, . His research interests have focused on pharmacologic methods to reduce pain in post-operative, cancer and hospice patients. He currently conducts a research study using THC to improve analgesia in patients presenting with chronic neuropathic pain. He created the term ''Suicidogen": any factor that causes a person to think about and possibly commit suicide [can be searched onthe internet] In addition to his teaching and research at PCOM, he lectures in pharmacology at the University of Pennsylvania School Of Dental Medicine.Dr. Goldstein serves on the editorial board of, and reviews submissions for, the Journal of Opioid Management. He is an active member of the National Board of Osteopathic Medical Examiners where he writes and reviews questions for the COMLEX Level 1 test.

Watsapp